CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 158 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $845,240 | +66.0% | 22,000 | 0.0% | 0.21% | +55.6% |
| Q1 2023 | $509,300 | -11.6% | 22,000 | 0.0% | 0.14% | -20.6% |
| Q4 2022 | $576,400 | -8.4% | 22,000 | -31.2% | 0.17% | -13.7% |
| Q3 2022 | $629,000 | -5.4% | 32,000 | -15.8% | 0.20% | +4.2% |
| Q2 2022 | $665,000 | +14.5% | 38,000 | +7.0% | 0.19% | +40.0% |
| Q1 2022 | $581,000 | +85.0% | 35,500 | +84.5% | 0.14% | +104.5% |
| Q4 2021 | $314,000 | +28.2% | 19,239 | 0.0% | 0.07% | +20.0% |
| Q3 2021 | $245,000 | -9.9% | 19,239 | 0.0% | 0.06% | -8.3% |
| Q2 2021 | $272,000 | -30.6% | 19,239 | -23.8% | 0.06% | -36.8% |
| Q1 2021 | $392,000 | -86.4% | 25,239 | -86.1% | 0.10% | -85.7% |
| Q4 2020 | $2,887,000 | – | 182,036 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $135,241,466 | 29.11% |
| Octagon Capital Advisors LP | 2,551,703 | $66,854,619 | 10.41% |
| Affinity Asset Advisors, LLC | 818,035 | $21,432,517 | 8.40% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $113,853,646 | 7.08% |
| Saturn V Capital Management LP | 423,177 | $6,728,298 | 5.58% |
| Altium Capital Management LP | 385,000 | $10,087,000 | 5.13% |
| Deep Track Capital, LP | 3,000,000 | $78,600,000 | 3.30% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 340,389 | $8,914,788 | 2.75% |
| Vivo Capital, LLC | 872,151 | $22,850 | 2.63% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,985,490 | 2.06% |